GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Assertio Holdings Inc (FRA:DPOA) » Definitions » Cyclically Adjusted PB Ratio

Assertio Holdings (FRA:DPOA) Cyclically Adjusted PB Ratio : (As of Jun. 07, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Assertio Holdings Cyclically Adjusted PB Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PB Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Assertio Holdings Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Assertio Holdings's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Assertio Holdings Cyclically Adjusted PB Ratio Chart

Assertio Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.40 0.11 0.17 0.32 0.08

Assertio Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.47 0.40 0.19 0.08 0.07

Competitive Comparison of Assertio Holdings's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Assertio Holdings's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Assertio Holdings's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Assertio Holdings's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Assertio Holdings's Cyclically Adjusted PB Ratio falls into.



Assertio Holdings Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Assertio Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Assertio Holdings's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.521/131.7762*131.7762
=1.521

Current CPI (Mar. 2024) = 131.7762.

Assertio Holdings Quarterly Data

Book Value per Share CPI Adj_Book
201406 2.259 100.560 2.960
201409 3.482 100.428 4.569
201412 4.985 99.070 6.631
201503 5.572 99.621 7.370
201506 5.113 100.684 6.692
201509 5.043 100.392 6.620
201512 4.758 99.792 6.283
201603 4.413 100.470 5.788
201606 4.309 101.688 5.584
201609 4.207 101.861 5.443
201612 3.837 101.863 4.964
201703 3.456 102.862 4.427
201706 2.988 103.349 3.810
201709 2.645 104.136 3.347
201712 2.259 104.011 2.862
201803 2.631 105.290 3.293
201806 2.561 106.317 3.174
201809 3.249 106.507 4.020
201812 3.017 105.998 3.751
201903 2.869 107.251 3.525
201906 2.696 108.070 3.287
201909 2.796 108.329 3.401
201912 0.645 108.420 0.784
202003 0.935 108.902 1.131
202006 0.928 108.767 1.124
202009 0.793 109.815 0.952
202012 0.561 109.897 0.673
202103 1.087 111.754 1.282
202106 0.941 114.631 1.082
202109 1.012 115.734 1.152
202112 1.114 117.630 1.248
202203 1.249 121.301 1.357
202206 1.493 125.017 1.574
202209 1.675 125.227 1.763
202212 2.620 125.222 2.757
202303 2.878 127.348 2.978
202306 2.885 128.729 2.953
202309 2.222 129.860 2.255
202312 1.556 129.419 1.584
202403 1.521 131.776 1.521

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Assertio Holdings  (FRA:DPOA) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Assertio Holdings Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Assertio Holdings's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Assertio Holdings (FRA:DPOA) Business Description

Traded in Other Exchanges
Address
100 South Saunders Road, Suite 300, Lake Forest, IL, USA, 60045
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults 18 years of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Assertio Holdings (FRA:DPOA) Headlines

No Headlines